As expected, The Drug Enforcement Administration (DEA) published a new regulation on November 19, 2024, that temporarily extends the COVID-era flexibilities for prescribing controlled substances via telemedicine...
Following significant pressure from both Congress and the White House, the DEA submitted a proposed rule on October 11, 2024, aimed at maintaining telemedicine prescribing flexibilities for controlled substances...